Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$16,483,922
+$678,432 QoQ
Shares Held
64,905
+0.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#837
of 4,676 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Callan Family Office, LLC holds $198,735,685 across 16 Drug Manufacturers - General names. JNJ ranks #3 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
54,722 | $65,635,213 | |
| 2 | NVS |
Novartis AG
|
107,922 | $16,913,535 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
64,905 | $16,483,922 | |
| 4 | ABBV |
AbbVie Inc.
|
58,732 | $14,779,320 | |
| 5 | GSK |
GSK plc
|
271,081 | $14,210,066 | |
| 6 | MRK |
Merck & Co., Inc.
|
107,070 | $13,758,495 | |
| 7 | AZN |
Astrazeneca PLC
|
69,688 | $13,214,238 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
101,450 | $12,817,193 |
All Filings in JNJ
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,483,922 | 64,905 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $15,805,490 | 64,660 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $13,948,016 | 67,398 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $10,109,098 | 54,520 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $8,574,774 | 56,136 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $5,367,245 | 32,364 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,222,806 | 36,114 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,585,432 | 9,783 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $1,033,643 | 7,072 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $859,288 | 5,432 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $862,070 | 5,500 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $814,572 | 5,230 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $936,843 | 5,660 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $915,895 | 5,909 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $779,733 | 4,414 | Shares | Sole | 2023-02-23 | |
| No filing history on record for this holder in this stock. | ||||||